Amwell, Leidos selected by U.S. Defense Health Agency for ‘Digital First’ effort

Amwell (AMWL), totgether with Leidos (LDOS), was recently awarded a next-generation contract to provide a hybrid care technology platform designed to power the “Digital First” transformation of the Military Health System. Under this task order, the Leidos Partnership for Defense Health will deliver Amwell Converge, a comprehensive hybrid care enablement platform designed to power the full continuum of care using digital, virtual and automated modalities, and replace the Military Health System Video Connect solution. It will start at five initial sites followed by a phased enterprise roll-out. Also included in the contract are a broad spectrum of Amwell automated care programs that have a proven track record of helping deliver better health outcomes, including multiple behavioral health and integrated core telehealth solutions. If all options are exercised, the task order has a 22-month period of performance with a total value of up to $180M to the LPDH. “Through our world class platform Converge, Amwell is already enabling hybrid care across the commercial marketplace. With this agreement, we are pleased to offer our unique capabilities and help improve access to quality care for the MHS community of users. We are grateful for their service, and honored to have been chosen to join Leidos in supporting the Department of Defense as it seeks to adopt and extend the benefits of hybrid care to the Military Health System,” said Ido Schoenberg, M.D., chairman and CEO of Amwell.